CA2500836A1 - Materiaux et compositions metalliferes, et procedes associes - Google Patents

Materiaux et compositions metalliferes, et procedes associes Download PDF

Info

Publication number
CA2500836A1
CA2500836A1 CA002500836A CA2500836A CA2500836A1 CA 2500836 A1 CA2500836 A1 CA 2500836A1 CA 002500836 A CA002500836 A CA 002500836A CA 2500836 A CA2500836 A CA 2500836A CA 2500836 A1 CA2500836 A1 CA 2500836A1
Authority
CA
Canada
Prior art keywords
silver
conditions
nanocrystalline
condition
atomically disordered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002500836A
Other languages
English (en)
Inventor
Robert E. Burrell
John B. Wright
Kan Lam
Hua Qing Yin
Antony G. Naylor
Peter H. Moxham
Scott H. Gillis
Paul Schechter
James Alexander Robert Stiles
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith and Nephew Overseas Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/277,358 external-priority patent/US20030185901A1/en
Priority claimed from US10/277,673 external-priority patent/US20030180379A1/en
Priority claimed from US10/277,298 external-priority patent/US6989157B2/en
Priority claimed from US10/277,356 external-priority patent/US20030170314A1/en
Priority claimed from US10/277,362 external-priority patent/US20030194444A1/en
Priority claimed from US10/277,320 external-priority patent/US20030206966A1/en
Application filed by Individual filed Critical Individual
Publication of CA2500836A1 publication Critical patent/CA2500836A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention porte sur des matériaux et compositions métallifères, et les procédés associés. Un tel matériau peut par exemple être un antimicrobien, un anti-film bio, un antibactérien, un anti-inflammatoire, un antifongique, un antiviral, un anticancéreux, un pro-apoptose, un anti-prolifération, un modulateur de la MMP, un corps cristallin à désordre atomique, et/ou un corps nanocristallin. Dans certaines exécutions, le matériau métallifère est un corps nanocristallin argentifère à désordre atomique.
CA002500836A 2002-10-22 2003-10-22 Materiaux et compositions metalliferes, et procedes associes Abandoned CA2500836A1 (fr)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US10/277,358 US20030185901A1 (en) 2000-07-27 2002-10-22 Methods of treating conditions with a metal-containing material
US10/277,298 2002-10-22
US10/277,673 US20030180379A1 (en) 2000-07-27 2002-10-22 Solutions and aerosols of metal-containing compounds
US10/277,298 US6989157B2 (en) 2000-07-27 2002-10-22 Dry powders of metal-containing compounds
US10/277,356 2002-10-22
US10/277,356 US20030170314A1 (en) 2000-07-27 2002-10-22 Compositions of metal-containing compounds
US10/277,362 US20030194444A1 (en) 2000-07-27 2002-10-22 Methods of treating skin and integument conditions
US10/277,673 2002-10-22
US10/277,320 2002-10-22
US10/277,362 2002-10-22
US10/277,358 2002-10-22
US10/277,320 US20030206966A1 (en) 2000-07-27 2002-10-22 Methods of inducing apoptosis and modulating metalloproteinases
US10/364,983 2003-02-12
US10/364,983 US7078060B2 (en) 2000-07-27 2003-02-12 Solutions and aerosols of metal-containing compounds
PCT/US2003/033446 WO2004037187A2 (fr) 2002-10-22 2003-10-22 Matériaux et compositions metalliferes, et procédés associés

Publications (1)

Publication Number Publication Date
CA2500836A1 true CA2500836A1 (fr) 2004-05-06

Family

ID=32180857

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002500836A Abandoned CA2500836A1 (fr) 2002-10-22 2003-10-22 Materiaux et compositions metalliferes, et procedes associes

Country Status (4)

Country Link
EP (1) EP1575552A4 (fr)
AU (1) AU2003287183A1 (fr)
CA (1) CA2500836A1 (fr)
WO (1) WO2004037187A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2460585A1 (fr) 2003-05-16 2004-11-16 Exciton Technologies Inc. Produits de revetement par depot, materiaux composites et methodes de production connexes
WO2009085651A1 (fr) * 2007-12-20 2009-07-09 Nucryst Pharmaceuticals Corp. Particules de carbonate de métal et leurs méthodes d'obtention

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2200723A1 (de) * 1972-01-07 1973-07-19 Fresenius Chem Pharm Ind Salbe zur behandlung von epithelschaeden der haut
SU980695A1 (ru) * 1981-03-13 1982-12-15 Московский научно-исследовательский институт туберкулеза Способ лечени кавернозного туберкулеза легких
US5374432A (en) * 1989-07-28 1994-12-20 The Trustees Of Columbia University Of The City Of New York Topical anti-infective ointment containing silver or silver salts and antibiotics
US6258385B1 (en) * 1999-04-22 2001-07-10 Marantech Holding, Llc Tetrasilver tetroxide treatment for skin conditions
US6989156B2 (en) * 2001-04-23 2006-01-24 Nucryst Pharmaceuticals Corp. Therapeutic treatments using the direct application of antimicrobial metal compositions

Also Published As

Publication number Publication date
EP1575552A2 (fr) 2005-09-21
AU2003287183A1 (en) 2004-05-13
EP1575552A4 (fr) 2011-05-25
WO2004037187A8 (fr) 2004-07-22
AU2003287183A8 (en) 2004-05-13
WO2004037187A2 (fr) 2004-05-06
WO2004037187A3 (fr) 2004-09-02

Similar Documents

Publication Publication Date Title
US7255881B2 (en) Metal-containing materials
US6989157B2 (en) Dry powders of metal-containing compounds
US7470437B2 (en) Methods of treating conditions with a metal-containing material
US7201925B2 (en) Treatment of ungual and subungual diseases
US20030170314A1 (en) Compositions of metal-containing compounds
US7078060B2 (en) Solutions and aerosols of metal-containing compounds
EP1383522B1 (fr) Traitement d'etats inflammatoires de la peau
US20040191329A1 (en) Compositions and methods of metal-containing materials
AU2002303438A1 (en) Therapeutic treatments using the direct application of antimicrobial metal compositions
WO2004037186A2 (fr) Methodes de traitement prophylactique
US7001617B2 (en) Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals
US20030194444A1 (en) Methods of treating skin and integument conditions
US7427416B2 (en) Methods of treating conditions using metal-containing materials
US20030206966A1 (en) Methods of inducing apoptosis and modulating metalloproteinases
US20060115541A1 (en) Treatment of bladder conditions
CA2500836A1 (fr) Materiaux et compositions metalliferes, et procedes associes
AU2002252880A1 (en) Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use to induce apoptosis in cancerous tissue

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead

Effective date: 20150707